General Information
Revision date
2016-11-16
Product name
MULTAQ (dronedarone) Tablets
Substance name
Dronedarone hydrochloride
CAS No.
141625-93-6
1.2.1 Relevant identified uses
Pharmaceutical product
supplier name
Sanofi-aventis U.S. LLC A SANOFI Company
Icons in SDS
Company Information
company name
Sanofi-aventis U.S. LLC A SANOFI Company
Section 2
OSHA HCS Classification
Classification of the finished drug product is not required according to OSHA 29 CFR 1910.1200. The following information is provided for the drug substance, dronedarone hydrochloride:
2.1 Classification of the substance or mixture
Eye damage/irritation, Category 2A 2.2 Label elements in accordance with 29 CFR 1910.1200 Labeling of the finished drug product is not required according to OSHA 29 CFR 1910.1200. The following information is provided for the drug substance, dronedarone hydrochloride:
Hazard statements
Causes serious eye irritation
Hazard pictograms
Exclamation mark
Prevention
Wash hands thoroughly after handling. Wear eye protection (see Section 8)
Response
If in eyes Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. If eye irritation persists: Get medical attention.
Storage
Store in a well-ventilated place. Keep container tightly closed
Disposal
Disposal should be in accordance with applicable regional, national and local laws and regulations.
2.3 Other hazards
No information available.
